Saturday, July 11, 2026

biotech · ALK-positive Non-small Cell Lung Cancer · Biliary Tract Carcinoma

Zelgen Biopharmaceuticals

News and analysis for Zelgen Biopharmaceuticals on NovaPharmaNews — regulatory, clinical, and market coverage.

Kunshan, CN HQ
8 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Kunshan, CN
Employees
8
Programs
3
Drugs
7
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Zelgen Biopharmaceuticals — regulatory, clinical, and market coverage.

News and analysis for Zelgen Biopharmaceuticals on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Zelgen Biopharmaceuticals yet.

Back to company overview →